S&P 500   3,306.51 (+0.36%)
DOW   26,828.47 (+0.62%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   3,306.51 (+0.36%)
DOW   26,828.47 (+0.62%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   3,306.51 (+0.36%)
DOW   26,828.47 (+0.62%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   3,306.51 (+0.36%)
DOW   26,828.47 (+0.62%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
Log in

NYSEAMERICAN:CVRSCorindus Vascular Robotics Stock Price, Forecast & News

$4.27
0.00 (0.00 %)
(As of 11/27/2019)
Add
Compare
Today's Range
$4.27
Now: $4.27
$4.27
50-Day Range N/A
52-Week Range
$0.78
Now: $4.27
$4.40
VolumeN/A
Average Volume1.99 million shs
Market Capitalization$891.08 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.
Read More
Corindus Vascular Robotics logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.66 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:CVRS
Previous SymbolNYSEMKT:CVRS
CUSIPN/A
CIKN/A
Phone+1-508-6533335

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees90
Market Cap$891.08 million
Next Earnings DateN/A
OptionableNot Optionable
$4.27
0.00 (0.00 %)
(As of 11/27/2019)
30 days | 90 days | 365 days | Advanced Chart

Receive CVRS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVRS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Corindus Vascular Robotics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corindus Vascular Robotics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Corindus Vascular Robotics
.

How were Corindus Vascular Robotics' earnings last quarter?

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) posted its quarterly earnings results on Tuesday, August, 7th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.05) by $0.01. The medical equipment provider earned $1.67 million during the quarter, compared to analysts' expectations of $3 million.
View Corindus Vascular Robotics' earnings history
.

What price target have analysts set for CVRS?

1 equities research analysts have issued 1 year target prices for Corindus Vascular Robotics' stock. Their forecasts range from $4.28 to $4.28. On average, they expect Corindus Vascular Robotics' share price to reach $4.28 in the next twelve months. This suggests a possible upside of 0.2% from the stock's current price.
View analysts' price targets for Corindus Vascular Robotics
.

Has Corindus Vascular Robotics been receiving favorable news coverage?

Headlines about CVRS stock have been trending very negative this week, InfoTrie reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Corindus Vascular Robotics earned a coverage optimism score of -3.6 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an effect on the company's share price in the next few days.
View the latest news about Corindus Vascular Robotics
.

Who are some of Corindus Vascular Robotics' key competitors?

What other stocks do shareholders of Corindus Vascular Robotics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Corindus Vascular Robotics investors own include Amarin (AMRN), TransEnterix (TRXC), Micron Technology (MU), Advanced Micro Devices (AMD), Helios and Matheson Analytics (HMNY), Alibaba Group (BABA), TherapeuticsMD (TXMD), Exelixis (EXEL), NVIDIA (NVDA) and Protalix Biotherapeutics (PLX).

Who are Corindus Vascular Robotics' key executives?

Corindus Vascular Robotics' management team includes the following people:
  • Mr. Mark J. Toland, CEO, Pres & Director (Age 49)
  • Mr. David W. Long, CFO, Sr. VP, Sec. & Treasurer (Age 49)
  • Mr. Douglas Teany, Chief Operating Officer (Age 47)
  • Ms. Nora Dutta, Sr. VP of HR
  • Dr. J. Aaron Grantham, Chief Medical Officer of Cardiovascular

What is Corindus Vascular Robotics' stock symbol?

Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."

How do I buy shares of Corindus Vascular Robotics?

Shares of CVRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Corindus Vascular Robotics' stock price today?

One share of CVRS stock can currently be purchased for approximately $4.27.

How big of a company is Corindus Vascular Robotics?

Corindus Vascular Robotics has a market capitalization of $891.08 million. Corindus Vascular Robotics employs 90 workers across the globe.

What is Corindus Vascular Robotics' official website?

The official website for Corindus Vascular Robotics is www.corindus.com.

How can I contact Corindus Vascular Robotics?

Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.